Therapeutic Exercise to Treat Neuropathic Pain
Launched by UNIVERSIDAD DE ZARAGOZA · Aug 7, 2019
Trial Information
Current as of May 20, 2025
Completed
Keywords
ClinConnect Summary
There take part in this study women or men aged between 18 and 65 years, with a diagnosys by a physician specializing in Fabry disease with FabryScan. Patients must present a stable evolution, with a scoring system of disease severity (DS3) that must be less than 8 points per year in the last 2-3 years and they have to presence of neuropathic pain with a score greater than or equal to 4 in the questionnaire "Douleur neuropathique (DN4)".
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • Female or male patients between 18 years and 65 years.
- • Patients diagnosed by a doctor specializing in Fabry disease with FabryScan.
- • Fabry's disease must have a stable evolution, with a disease severity scoring system (DS3) that must be less than 8 points per year in the last 2-3 years.
- • Presence of neuropathic pain with a score greater than or equal to 4 in the "Douleur neuropathique (DN4)" questionnaire.
- Exclusion criteria:
- • Patients with an acute cardiovascular disease or with a heart or kidney transplant.
- • Subjects with acute orthopedic problems that limit their participation in the study.
- • Subjects with cognitive impairments that prevent them from filling in the questionnaires or understanding the exercises to be performed.
About Universidad De Zaragoza
The Universidad de Zaragoza, a prestigious institution in Spain, is dedicated to advancing scientific research and innovation through its clinical trial sponsorship. With a strong emphasis on interdisciplinary collaboration, the university fosters a robust environment for conducting high-quality clinical studies that aim to improve healthcare outcomes. Leveraging its extensive academic resources and expertise across various medical fields, the Universidad de Zaragoza is committed to ethical research practices and the promotion of evidence-based medicine, contributing to the advancement of knowledge and the betterment of patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zaragoza, , Spain
Patients applied
Trial Officials
Royo
Principal Investigator
Universidad San Jorge
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials